Final Program

258 TUESDAY • MAY 17
Facilitator:
P175
P176
P177
P178
P179
P180
C35
P. Burkett, MD, PhD, Boston, MA
Levels of Surfactant Protein D in Bronchial Aspirates Within
Six Hours of Lung Transplantation Are Associated with
Clinical Outcomes/J. Madsen, S. Rideout, L. Thakuria, R.
Romano, A. Simon, A. Popov, F. De Robertis, S. Soresi, M. Carby,
A. Reed, N. Marczin, H. Clark, M. Griffiths, Southampton, United
Kingdom, p.A4887
Prospective Molecular Profiling In Human Lung Allografts/F.
Laenger, N. Izykowski, J. Rische, P. Braubach, J. Gottlieb, T.
Welte, A. Haverich, G. Warnecke, H. Kreipe, M.P. Kuehnel, D.
Jonigk, Hannover, Germany, p.A4888
Ischemia Reperfusion-Induced Genetic Expression Profiles in
the Human Lung/B.S. Kim, L. Johnston, J.T. Magruder, J.C.
Grimm, C. Talbot, R.S. Stephens, M. Damarla, R.L. Damico, P.M.
Hassoun, A.S. Shah, Baltimore, MD, p.A4889
Retention and Activation of Donor Vascular Monocytes in
Transplanted Lungs Suggests a Central Role in Primary Graft
Dysfunction/K.C. Tatham, K.P. O’Dea, R. Romano, H. Donaldson,
L. Thakuria, K. Wakabayashi, B.V. Patel, A. Reed, A. Simon, N.
Marczin, M. Takata, London, United Kingdom, p.A4890
Remodelling-Related Molecular Profiles in Different Subforms
of Chronic Lung Allograft Dysfunction/D. Jonigk, B. Rath, L.
Maegel, H. Golpon, N. Izykowski, T. Welte, S. Janciauskene, J.
Gottlieb, G. Warnecke, A. Haverich, H. Kreipe, M.P. Kuehnel, F.
Laenger, Hannover, Germany, p.A4891
Coordinated Immune Activation by Distinct Mononuclear
Phagocytes Subtypes Against the Mismatch of Minor
Antigens/C. Jakubzick, S. Atif, S. Gibbings, R. Gill, T. Grazia, R.
Torres, P.M. Henson, G. Randolph, Denver, CO, p.A7871
THEMATIC POSTER SESSION
INNATE IMMUNE MECHANISMS IN COPD
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area L, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1219
P1220
S. Garantziotis, MD, Research Triangle Park, NC
Inflammatory Airway Diseases Are Characterized by a
Microenvironment-Induced Sliding of Mast Cells into a
Gradually Increasing Chymase+, CPA3+, and Cathepsin+
Phenotype/P. Siddhuraj, M. Mori, A. Bergqvist, H.-J. Hoffman, L.
Bjermer, J. Erjefalt, Lund, Sweden, p.A4892
Expression and Function of Growth Differentiation Factor-15 in
Cigarette Smoke-Induced Inflammation and COPD/F.M.
Verhamme, L.J. Seys, E.G. De Smet, S. Provoost, D. Elewaut, G.F.
Joos, G.G. Brusselle, K.R. Bracke, Ghent, Belgium, p.A4893
P1221
P1222
P1223
Elevated Levels of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1)
in Lungs of Patients with COPD/E.G. De Smet, L.J. Seys, F.M.
Verhamme, B.M. Vanaudenaerde, G.F. Joos, G.G. Brusselle, C.D.
Bingle, K.R. Bracke, Ghent, Belgium, p.A4894
Inflammation Paradox - A Detailed Analysis of Inflammatory
Profile in the Large and Small Airway Wall in Mild to Moderate
Chronic Obstructive Pulmonary Disease (COPD) Patients/M.S.
Eapen, K.D. McAlinden, D. Tan, H.K. Muller, S.S. Sohal, E.H.
Walters, Hobart, Australia, p.A4895
The High-Affinity IgE Receptor Is Upregulated on Plasmacytoid
Dendritic Cells in Patients with Severe COPD/P. Stoll, A.
Baehker, M. Ulrich, K. Bratke, K. Garbe, J.C. Virchow, M.
Lommatzsch, Rostock, Germany, p.A4896
P1224 Platelets of COPD Patients Are Hyper-Responsive/F. Aleva, Q.
De Mast, K. Van Bragt, P. De Groot, Y. Heijdra, A. Van Der Ven,
Nijmegen, Netherlands, p.A4897
Facilitator:
P1225
P1226
P1227
P1228
P1229
P1230
Facilitator:
P1231
P1232
M. Divangahi, PhD, Montreal, Canada
Longitudinal Analysis Better Characterized Asthma-COPD
Overlap Syndrome (ACOS): Finding from the Korean Asthma
Cohort, COREA /S.-Y. Park, J. Lee, J.-H. Kim, H.-J. Kim, H.-S. Kwon,
Y.S. Cho, H.-B. Moon, T.-B. Kim, Seoul, Korea, Republic of, p.A4898
Inhibition of p38 MAPK in Human Skeletal Muscle Cells
Attenuates the SAA1 Secretion Initiated by Inflammatory
Stimulation and Could Be Helpful Against Muscle Targeted
Inflammation in COPD/D. Patoine, A. Dube, M.-E. ThAcriault, S.
Bonnet, F. Maltais, Quebec, Canada, p.A4899
Sputum Bacterial and Fungal Dynamics During Exacerbations
of Severe COPD/J. Su, H. Zhou, GuangZhou, China, p.A4900
Highly Selective Inhibitors of PI3Kg for the Oral Treatment of
COPD/K. Karabelas, S. Arlbrandt, P. Bold, A. Butcher, J.F.
Carlsson, P. Cygan, J. Ehnebom, C. Goodyear, L. MacLellan, M.
Nordberg, H. Lindmark, M. Mogemark, R. Pehrson, M. Perry, S.R.
Blomqvist, A. Stern, M. Thomas, Gothenburg, Sweden, p.A4901
Plasma Cytokines and Chemokines Are Associated with
Airflow Obstruction and Exacerbations in The COPDGene
Cohort/E.P. Bradford, S. Jacobson, B.C. Hartman, J. Keene, R.P.
Bowler, Denver, CO, p.A4902
An Impaired Innate Immune Response in Airway Smooth
Muscle Cells from Chronic Cough Patients/C. Rossios, S.
Pavlidis, D. Gibeon, D. Horowitz, P. Branigan, M. Loza, F.
Baribaud, N. Rao, F. Chung, I.M. Adcock, London, United Kingdom,
p.A4903
R. Shaykhiev, MD, PhD, New York, NY
IL17 Is Increased in Diseased Lung Tissue as Well as During
Respiratory Disease Exacerbations and Increases Airway
Contraction in Normal Human Lung Tissue/D. Mohn, L.
Sherman, K. Miner, C. Vezina, J.A. Johnston, Thousand Oaks, CA,
p.A4904
Complement Therapeutics Ameliorate Cigarette Smoke
Induced Emphysema Development and Progression/S.
Stephenson, A. Kirst, A. Alawieh, J.K. Mulligan, T. Williamson, N.
Reaves, S. Tomlinson, C. Atkinson, Charleston, SC, p.A4905
ATS 2016 • San Francisco